Peter Henriksson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Henriksson has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Amir Babiker
Department of Medical Laboratory Sciences and Technology, Karolinska Institutet, Huddinge University Hospital and Danderyd University Hospital, SE-182 88 Danderyd, Sweden
1 shared publicationAnna Freyschuss
Department of Medicine, Karolinska Institutet, Huddinge University Hospital, and Danderyd University Hospital, Danderyd, Sweden
1 shared publication- Anna Freyschuss
Department of Medicine, Karolinska University Hospital
1 shared publication Anna Kiessling
Centre for Clinical Education, Danderyd University Hospital and Karolinska Institute, SE-182 88 Stockholm, Sweden
1 shared publicationAyman Al-Schurbaji
Department of Medical Laboratory Sciences and Technology, Karolinska Institutet, Huddinge University Hospital and Danderyd University Hospital, SE-182 88 Danderyd, Sweden
1 shared publicationIda Löfman
Department of Medicine, Södertälje Hospital
1 shared publication
Latest Publications
- 1 January 2006
- Published by Wiley
- Vol. 85 (6) , 736-740
Preserved microcirculatory response to acute estrogen not reflected by exercise capacity
Background. To assess the acute effect of a single dose of 10 mg oral micronized 17β‐estradiol on microcirculation in postmenopausal women with and without coronary artery disease and its potential influence on exercise capacity. Methods. Postmenopausal women (n=11) with coronary artery disease had symptoms of ischemic heart disease and at least 1 mm ST depression at exercise. Microcirculation was examined by vital microscopy, with and without the acute administration of estrogen in a placebo‐controlled cross‐over design. Exercise test was performed on bicycle. The microcirculatory findings were contrasted to those in 14 healthy postmenopausal women. Results. 17β‐Estradiol in serum and blood flow velocity increased significantly after acute oral estrogen administration both in women with coronary artery disease (ppConclusions. Previously reported data that a single dose of estrogen administered to postmenopausal women results in positive effects on exercise was not reproduced. An increased peripheral microvascular flow velocity was detected in women with coronary artery disease and this increase was not accompanied by an increased exercise capacity.
- 1 January 2006
- Published by Wiley
- Vol. 85 (6) , 736-740
Preserved microcirculatory response to acute estrogen not reflected by exercise capacity
Background. To assess the acute effect of a single dose of 10 mg oral micronized 17β‐estradiol on microcirculation in postmenopausal women with and without coronary artery disease and its potential influence on exercise capacity. Methods. Postmenopausal women (n=11) with coronary artery disease had symptoms of ischemic heart disease and at least 1 mm ST depression at exercise. Microcirculation was examined by vital microscopy, with and without the acute administration of estrogen in a placebo‐controlled cross‐over design. Exercise test was performed on bicycle. The microcirculatory findings were contrasted to those in 14 healthy postmenopausal women. Results. 17β‐Estradiol in serum and blood flow velocity increased significantly after acute oral estrogen administration both in women with coronary artery disease (ppConclusions. Previously reported data that a single dose of estrogen administered to postmenopausal women results in positive effects on exercise was not reproduced. An increased peripheral microvascular flow velocity was detected in women with coronary artery disease and this increase was not accompanied by an increased exercise capacity.
- 10 April 2003
- Vol. 100 (15) , 1320-1
[Decision support in drug prescribing. A tool which must be well-functioning in a complex clinical reality].
- 10 April 2003
- Vol. 100 (15) , 1320-1
[Decision support in drug prescribing. A tool which must be well-functioning in a complex clinical reality].
Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study
Objective: To study the efficacy of case method learning, for general practitioners, on patients' lipid concentrations in the secondary prevention of coronary artery disease. Design: Prospective controlled trial. Setting: Södertälje, Stockholm County, Sweden. Participants: 255 consecutive patients with coronary artery disease. Intervention: Guidelines were mailed to all general practitioners (n=54) and presented at a common lecture. General practitioners who were randomised to the intervention group participated in recurrent case method learning dialogues at their primary healthcare centres during a two year period. A locally well known cardiologist served as a facilitator. Main outcome measure: Concentration of low density lipoprotein cholesterol at baseline and after two years. Analysis according to intention to treat (intervention and control groups (n=88)) was based on group affiliation at baseline. Results: Low density lipoprotein cholesterol was reduced by 0.5 mmol/l (95% confidence interval 0.2 to 0.8 mmol/l) (9.3% (2.9% to 15.8%)) from baseline in patients in the intervention group and by 0.5 (0.1 to 0.9) mmol/l compared with controls (PConclusion: Case method learning resulted in a lowering of low density lipoprotein cholesterol in the primary care patients with coronary artery disease comparable to that achieved at a specialist clinic. Conventional presentation of practice guidelines had no effect.
Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study
Objective: To study the efficacy of case method learning, for general practitioners, on patients' lipid concentrations in the secondary prevention of coronary artery disease. Design: Prospective controlled trial. Setting: Södertälje, Stockholm County, Sweden. Participants: 255 consecutive patients with coronary artery disease. Intervention: Guidelines were mailed to all general practitioners (n=54) and presented at a common lecture. General practitioners who were randomised to the intervention group participated in recurrent case method learning dialogues at their primary healthcare centres during a two year period. A locally well known cardiologist served as a facilitator. Main outcome measure: Concentration of low density lipoprotein cholesterol at baseline and after two years. Analysis according to intention to treat (intervention and control groups (n=88)) was based on group affiliation at baseline. Results: Low density lipoprotein cholesterol was reduced by 0.5 mmol/l (95% confidence interval 0.2 to 0.8 mmol/l) (9.3% (2.9% to 15.8%)) from baseline in patients in the intervention group and by 0.5 (0.1 to 0.9) mmol/l compared with controls (PConclusion: Case method learning resulted in a lowering of low density lipoprotein cholesterol in the primary care patients with coronary artery disease comparable to that achieved at a specialist clinic. Conventional presentation of practice guidelines had no effect.
- 27 November 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1534 (2-3) , 129-138
On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions
- 27 November 2001
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1534 (2-3) , 129-138
On the anti-atherogenic effect of the antioxidant BHT in cholesterol-fed rabbits: inverse relation between serum triglycerides and atheromatous lesions